Cargando…

Drinking Water–Associated PFAS and Fluoroethers and Lipid Outcomes in the GenX Exposure Study

BACKGROUND: Residents of Wilmington, North, Carolina, were exposed to drinking water contaminated by fluoroethers and legacy per- and polyfluoroalkyl substances (PFAS), such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), with fluoroether exposure occurring from 1980 to 2017....

Descripción completa

Detalles Bibliográficos
Autores principales: Rosen, Emma M., Kotlarz, Nadine, Knappe, Detlef R.U., Lea, C. Suzanne, Collier, David N., Richardson, David B., Hoppin, Jane A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Environmental Health Perspectives 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450637/
https://www.ncbi.nlm.nih.gov/pubmed/36069575
http://dx.doi.org/10.1289/EHP11033
_version_ 1784784565877866496
author Rosen, Emma M.
Kotlarz, Nadine
Knappe, Detlef R.U.
Lea, C. Suzanne
Collier, David N.
Richardson, David B.
Hoppin, Jane A.
author_facet Rosen, Emma M.
Kotlarz, Nadine
Knappe, Detlef R.U.
Lea, C. Suzanne
Collier, David N.
Richardson, David B.
Hoppin, Jane A.
author_sort Rosen, Emma M.
collection PubMed
description BACKGROUND: Residents of Wilmington, North, Carolina, were exposed to drinking water contaminated by fluoroethers and legacy per- and polyfluoroalkyl substances (PFAS), such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), with fluoroether exposure occurring from 1980 to 2017. PFOA and PFOS have previously been associated with metabolic dysfunction; however, few prior studies have examined associations between other PFAS and lipid levels. OBJECTIVES: We measured the association between serum fluoroether and legacy PFAS levels and various cholesterol outcomes. METHODS: Participants in the GenX Exposure Study contributed nonfasting blood samples in November 2017 and May 2018 that were analyzed for 20 PFAS (10 legacy, 10 fluoroethers) and serum lipids [total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides] and calculated non-HDL cholesterol. We estimated covariate-adjusted associations between quartiles of exposure to each of the PFAS measures (as well as the summed concentrations of legacy PFAS, fluoroethers, and all 10 targeted PFAS) and lipid outcomes by fitting inverse probability of treatment weighted linear regressions. RESULTS: In this cross-sectional study of 326 participants (age range 6–86 y), eight PFAS were detected in [Formula: see text] of the population. For PFOS and perfluorononanoic acid (PFNA), non-HDL cholesterol was approximately [Formula: see text] higher per exposure quartile increase: [PFOS: 4.89; 95% confidence interval (CI): 0.10, 9.68 and PFNA: 5.25 (95% CI: 0.39, 10.1)], whereas total cholesterol was approximately [Formula: see text] higher per quartile [PFOS: 5.71 (95% CI: 0.38, 11.0), PFNA: 5.92 (95% CI: 0.19, 11.7)]. In age-stratified analyses, associations were strongest among the oldest participants. Two fluoroethers were associated with higher HDL, whereas other fluoroether compounds were not associated with serum lipid levels. DISCUSSION: PFNA and PFOS were associated with higher levels of total and non-HDL cholesterol, with associations larger in magnitude among older adults. In the presence of these legacy PFAS, fluoroethers appeared to be associated with HDL but not non-HDL lipid measures. https://doi.org/10.1289/EHP11033
format Online
Article
Text
id pubmed-9450637
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Environmental Health Perspectives
record_format MEDLINE/PubMed
spelling pubmed-94506372022-09-09 Drinking Water–Associated PFAS and Fluoroethers and Lipid Outcomes in the GenX Exposure Study Rosen, Emma M. Kotlarz, Nadine Knappe, Detlef R.U. Lea, C. Suzanne Collier, David N. Richardson, David B. Hoppin, Jane A. Environ Health Perspect Research BACKGROUND: Residents of Wilmington, North, Carolina, were exposed to drinking water contaminated by fluoroethers and legacy per- and polyfluoroalkyl substances (PFAS), such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), with fluoroether exposure occurring from 1980 to 2017. PFOA and PFOS have previously been associated with metabolic dysfunction; however, few prior studies have examined associations between other PFAS and lipid levels. OBJECTIVES: We measured the association between serum fluoroether and legacy PFAS levels and various cholesterol outcomes. METHODS: Participants in the GenX Exposure Study contributed nonfasting blood samples in November 2017 and May 2018 that were analyzed for 20 PFAS (10 legacy, 10 fluoroethers) and serum lipids [total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides] and calculated non-HDL cholesterol. We estimated covariate-adjusted associations between quartiles of exposure to each of the PFAS measures (as well as the summed concentrations of legacy PFAS, fluoroethers, and all 10 targeted PFAS) and lipid outcomes by fitting inverse probability of treatment weighted linear regressions. RESULTS: In this cross-sectional study of 326 participants (age range 6–86 y), eight PFAS were detected in [Formula: see text] of the population. For PFOS and perfluorononanoic acid (PFNA), non-HDL cholesterol was approximately [Formula: see text] higher per exposure quartile increase: [PFOS: 4.89; 95% confidence interval (CI): 0.10, 9.68 and PFNA: 5.25 (95% CI: 0.39, 10.1)], whereas total cholesterol was approximately [Formula: see text] higher per quartile [PFOS: 5.71 (95% CI: 0.38, 11.0), PFNA: 5.92 (95% CI: 0.19, 11.7)]. In age-stratified analyses, associations were strongest among the oldest participants. Two fluoroethers were associated with higher HDL, whereas other fluoroether compounds were not associated with serum lipid levels. DISCUSSION: PFNA and PFOS were associated with higher levels of total and non-HDL cholesterol, with associations larger in magnitude among older adults. In the presence of these legacy PFAS, fluoroethers appeared to be associated with HDL but not non-HDL lipid measures. https://doi.org/10.1289/EHP11033 Environmental Health Perspectives 2022-09-07 /pmc/articles/PMC9450637/ /pubmed/36069575 http://dx.doi.org/10.1289/EHP11033 Text en https://ehp.niehs.nih.gov/about-ehp/licenseEHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.
spellingShingle Research
Rosen, Emma M.
Kotlarz, Nadine
Knappe, Detlef R.U.
Lea, C. Suzanne
Collier, David N.
Richardson, David B.
Hoppin, Jane A.
Drinking Water–Associated PFAS and Fluoroethers and Lipid Outcomes in the GenX Exposure Study
title Drinking Water–Associated PFAS and Fluoroethers and Lipid Outcomes in the GenX Exposure Study
title_full Drinking Water–Associated PFAS and Fluoroethers and Lipid Outcomes in the GenX Exposure Study
title_fullStr Drinking Water–Associated PFAS and Fluoroethers and Lipid Outcomes in the GenX Exposure Study
title_full_unstemmed Drinking Water–Associated PFAS and Fluoroethers and Lipid Outcomes in the GenX Exposure Study
title_short Drinking Water–Associated PFAS and Fluoroethers and Lipid Outcomes in the GenX Exposure Study
title_sort drinking water–associated pfas and fluoroethers and lipid outcomes in the genx exposure study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450637/
https://www.ncbi.nlm.nih.gov/pubmed/36069575
http://dx.doi.org/10.1289/EHP11033
work_keys_str_mv AT rosenemmam drinkingwaterassociatedpfasandfluoroethersandlipidoutcomesinthegenxexposurestudy
AT kotlarznadine drinkingwaterassociatedpfasandfluoroethersandlipidoutcomesinthegenxexposurestudy
AT knappedetlefru drinkingwaterassociatedpfasandfluoroethersandlipidoutcomesinthegenxexposurestudy
AT leacsuzanne drinkingwaterassociatedpfasandfluoroethersandlipidoutcomesinthegenxexposurestudy
AT collierdavidn drinkingwaterassociatedpfasandfluoroethersandlipidoutcomesinthegenxexposurestudy
AT richardsondavidb drinkingwaterassociatedpfasandfluoroethersandlipidoutcomesinthegenxexposurestudy
AT hoppinjanea drinkingwaterassociatedpfasandfluoroethersandlipidoutcomesinthegenxexposurestudy